Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | ||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | 99,437 | 847,506 | 2,118,700 | 1,004,262 | 982,259 | 5,052,164 |
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | 99,437 | 847,506 | 2,118,700 | 1,004,262 | 982,259 | 5,052,164 |
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | 5,052,164 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | 99,437 | 847,506 | 2,118,700 | 1,004,262 | 982,259 | 5,052,164 |
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | 1 | 8 | 1,157 | 2,348 | 5,456 | 8,970 |
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | 1 | 8 | 1,157 | 2,348 | 5,456 | 8,970 |
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | 4,347 | 4,347 | ||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | 103,785 | 847,514 | 2,119,857 | 1,006,610 | 987,715 | 5,065,481 |
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2022 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2022 |
(iii) Distributable Amount for 2022 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2022 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2022 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2022: | ||||
| a From 2017....... | ||||
| b From 2018....... | ||||
| c From 2019....... | ||||
| d From 2020....... | ||||
| e From 2021....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2022 distributable amount | ||||
|
i
Carryover from 2017 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2022 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2022 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2022, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2022. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2023. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2018..... | ||||
| b Excess from 2019..... | ||||
| c Excess from 2020..... | ||||
| d Excess from 2021..... | ||||
| e Excess from 2022..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| FORM 990 - ORGANIZATION'S MISSION | THE RP FOUNDATION'S MISSION IS TO: (A) INCREASE AWARENESS ABOUT RELAPSING POLYCHONDRITIS; (B) PROVIDE SUPPORT (PRIMARILY THROUGH THE USE OF THE INTERNET, SOCIAL MEDIA, AND PATIENT ADVOCACY PROGRAMS) FOR THOSE WHO ARE AFFECTED BY RELAPSING POLYCHONDRITIS, SUPPORT RESEARCH TO ADVANCE A CURE FOR RELAPSING POLYCHONDRITIS; (C) PROMOTE QUALITY CARE FOR RELAPSING POLYCHONDRITIS PATIENTS; AND (D) ENGAGE IN SUCH OTHER ACTIVITIES IN CONNECTION THEREWITH THAT THE BOARD OF DIRECTORS MAY AUTHORIZE, IN ALL CASES SUBJECT TO THE PROVISION OF SECTION 501(C)(3) OF THE INTERNAL REVENU CODE OF 1986, AS AMENDED, OR THE CORRESPONDING PROVISIONS OF ANY SUBSEQUENT FEDERAL TAX LAW (THE "CODE"). |
| FORM 990, PAGE 2, PART III, LINE 4A | AWARENESS: THE RELAPSING POLYCHONDRITIS FOUNDATION (RP FOUNDATION) PARTNERED WITH RACE FOR RP AND SIX INTERNATIONALLY RECOGNIZED MOTORSPORTS TEAMS TO PROUDLY SHOWCASE OUR LOGO AND PROMOTE OUR PURPOSE. THE FOUNDATION LAUNCHED FULL THROTTLE, A NEW RP AWARENESS PODCAST, HOSTED BY GREG CREAMER. FULL THROTTLE PROVIDED EXCLUSIVE INTERVIEWS AND INSIGHTS REGARDING RP, RELATED AUTOIMMUNE DISEASES, AND RACING TO ENGAGE AND ENERGIZE MOTORSPORTS FANS. IT ALSO FEATURED FOUNDATION-SUPPORTED COLLABORATIVE RESEARCH PROJECTS THAT ARE ADVANCING CLINICAL KNOWLEDGE REGARDING RP AND USHERING IN A NEW ERA OF HOPE FOR PATIENTS WITH RP. CBS SPORTS INTERVIEWED THE RP FOUNDATION DURING THE NASHVILLE GRAND PRIX AND FEATURED RACE FOR RP DURING THE FERRARI CHALLENGE NORTH AMERICA. THE RP FOUNDATION LAUNCHED A YOUTUBE CHANNEL AND IGNITED COMMUNICATION VIA SOCIAL PLATFORMS AND AN ENEWSLETTER TO INCREASE AWARENESS AND SUPPORT FOR THE INNOVATIVE RESEARCH THAT THE FOUNDATION IS INVESTING IN. AS A RESULT OF ROBUST COMMUNICATIONS ACROSS ALL SOCIAL MEDIA CHANNELS, THE RP FOUNDATION EXPERIENCED SUBSTANTIAL GROWTH IN THE NUMBER OF FOLLOWERS, WITH ENEWSLETTERS DEMONSTRATING A 60% OPEN RATE (SIGNIFICANTLY EXCEEDING INDUSTRY STANDARDS). |
| FORM 990, PAGE 2, PART III, LINE 4B | RESEARCH: THE RP FOUNDATION MADE SIGNIFICANT INVESTMENTS IN COLLABORATIVE RESEARCH THAT HELPED DRIVE RP AND RELATED AUTOIMMUNE DISEASES TO THE FOREFRONT OF GROUND-BREAKING DISCOVERIES. THE FOUNDATION SUPPORTED RESEARCH BEING CONDUCTED AT THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER AND NYU GROSSMAN SCHOOL OF MEDICINE TO SEARCH FOR GENETIC MARKERS IN PATIENTS WITH RP-RELATED AUTOIMMUNE DISEASE AND BONE MARROW DISEASES. THIS STUDY IS EXPLORING THE MECHANISMS OF PROGRESSION OF RELAPSING POLYCHONDRITIS (RP) TO MYELODYSPLASTIC SYNDROMES (MDS) AND BLOOD-BASED MALIGNANCIES AND WILL MAP THE HEMATOLOGIC CHANGES THAT TAKE PLACE DURING THE TRAJECTORY OF DISEASE USING STATE-OF-THE-ART GENETIC AND TRANSCRIPTOMIC APPROACHES. THE FOUNDATION'S INVESTMENTS IN THE NYU GROSSMAN SCHOOL OF MEDICINE AND NIH VEXAS (VACUOLES, E1 ENZYME, X-LINKED, AUTOINFLAMMATORY, SOMATIC) SYNDROME RESEARCH CONTINUES TO ADVANCE SCIENTIFIC KNOWLEDGE AND IMPROVE PATIENT CARE. IN 2022, VEXAS WAS DEEMED THE "YEAR'S BEST ADVANCEMENT IN HEMATOLOGY-RELATED DIAGNOSES" BY THE AMERICAN SOCIETY OF HEMATOLOGY. CLINICAL SCIENTISTS BELIEVE KNOWLEDGE GAINED FROM VEXAS RESEARCH WILL POTENTIALLY IMPROVE THE CLASSIFICATION OF BLOOD-BASED AND ADULT-ONSET RECURRENT AUTOIMMUNE DISEASES LIKE RELAPSING POLYCHONDRITIS. VEXAS SYNDROME RESEARCH ALSO BROUGHT SEVERAL AUTOIMMUNE DISEASES CLOSER TO THE DISCOVERY OF A BIOMARKER BY DEMONSTRATING THAT AUTOIMMUNE DISORDERS PREVIOUSLY THOUGHT TO BE UNRELATED TO EACH OTHER, LIKE RELAPSING POLYCHONDRITIS (RP), POLYARTERITIS NODOSA, SWEET SYNDROME, AND GIANT CELL ARTERITIS, SHARE A COMMON ACQUIRED, SOMATIC MUTATION IN THE UBA1 GENE. TWO GLOBALLY RENOWNED HEALTHCARE ORGANIZATIONS, THE INTERNATIONAL CONSENSUS CLASSIFICATION SYSTEM (ICC) AND THE WORLD HEALTH ORGANIZATION (WHO), ADDED VEXAS TO THEIR CLASSIFICATION SYSTEMS FOR HEMATOLOGICAL CANCERS. THE ICC LISTED VEXAS UNDER THE SPECTRUM OF PRE-MALIGNANT "CLONAL CYTOPENIAS,- AND THE WHO ACKNOWLEDGED THE CLOSE RELATIONSHIP BETWEEN SYSTEMIC INFLAMMATION, CLONAL SOMATIC MUTATIONS, AND MYELOID MALIGNANCIES BASED ON DATA FROM VEXAS WITH UBA1 MUTATIONS AND OTHER EMERGING ENTITIES. THE INCLUSION OF VEXAS IN THE CLASSIFICATION RESOURCES THAT CLINICIANS USE TO CATEGORIZE BLOOD-BASED CANCERS IS EXTREMELY IMPORTANT. IT INCREASES AWARENESS OF VEXAS AND RELATED SYSTEMIC INFLAMMATORY DISEASES AMONG CLINICIANS AND PATHOLOGISTS AND PROMOTES A HOLISTIC APPROACH TO PATIENT CARE, FROM DIAGNOSIS TO POST- DIAGNOSIS MANAGEMENT. THE RP FOUNDATION INVESTED IN THE NEXT PHASE OF VEXAS RESEARCH THAT'S SEARCHING FOR ADDITIONAL GENETIC MUTATIONS IN PATIENTS WITH AUTOIMMUNE DISEASES AND IS BEING CONDUCTED BY A COLLABORATIVE NETWORK OF TALENTED RESEARCHERS IN THE INFLAMMATORY DISEASE GENETICS PROGRAM AT NYU LANGONE AND THE RELAPSING POLYCHONDRITIS AND AUTOINFLAMMATORY CLINICS AT THE NATIONAL INSTITUTES OF HEALTH (NIH). THE RP FOUNDATION ALSO ASSISTED IN THE ESTABLISHMENT OF THE VEXAS FOUNDATION TO HELP PROVIDE A RESOURCE FOR VEXAS PATIENTS, RESEARCHERS, AND CLINICIANS. ADDITIONALLY, THE FOUNDATION SUPPORTED PURPOSE BIOBANK WHICH WILL CREATE A CENTRALIZED, STATE-OF-THE-ART COLLECTION OF CLINICAL AND RESEARCH DATA SO RESEARCHERS CAN VASTLY IMPROVE OUR COLLECTIVE UNDERSTANDING OF RELAPSING POLYCHONDRITIS AND RELATED DISEASES. THE FOUNDATION ALSO SUPPORTED THE "FRIENDS OF PATIENTS AT NIH RP FUND" WHICH IS ADMINISTERED BY THE NIH AND PROVIDES FUNDING FOR TRAVEL AND LODGING TO ELIGIBLE PATIENTS TRAVELING TO THE NIH FOR TREATMENT. |
| FORM 990, PAGE 2, PART III, LINE 4C | EDUCATION: THE RP FOUNDATION SUPPORTED SEVERAL RP PATIENTS, ADVOCATES, AND RESEARCHERS WHO EXHIBITED AT THIS YEAR'S RARE DISEASE DAY AT THE NATIONAL INSTITUTES OF HEALTH. THIS YEAR'S RARE DISEASE DAY EXHIBITS INCLUDED A PRESENTATION BY MIKE LINN, DIRECTOR OF THE RP FOUNDATION, AND DR. MARCELA FERRADA, RESEARCHER AT THE NIH. THEIR PRESENTATION TITLED, "WHERE THERE IS RESEARCH, THERE IS HOPE", HIGHLIGHTED THE COLLABORATIVE RESEARCH INITIATIVES THE RP FOUNDATION SUPPORTS AND DISCUSSED HOW THESE PROJECTS BRING PATIENTS HOPE. THE FOUNDATION ALSO SUPPORTED RP PATIENT, MELISSA ALLMAN, PH.D.'S SCIENTIFIC POSTER TITLED, "IT IS DUE TO STRESS - BUT WHICH TYPE OF STRESS?" WHICH WAS SELECTED FOR DISPLAY AT THE AMERICAN COLLEGE OF RHEUMATOLOGY'S (ACR) ANNUAL MEETING IN PHILADELPHIA, PA. |
| FORM 990, PAGE 2, PART III, LINE 4D | FUNDRAISING FUNDRAISING FUELS AND DRIVES THE RP FOUNDATION'S RESEARCH INITIATIVES. IN 2022, THE FOUNDATION INVESTED IN INNOVATIVE, ENGAGING WAYS TO RAISE FUNDS. THE HIGHLIGHTS INCLUDE: "INAUGURAL RP WARRIOR 5K WALK. ORGANIZED BY RP WARRIOR, DAN SMITH, THE INAUGURAL 5K WARRIOR WALK WAS A TREMENDOUS SUCCESS. FROM CALIFORNIA TO FLORIDA AND EVEN CANADA TO ISRAEL, RP WARRIORS AND THEIR SUPPORTERS SHOWED UP IN A BIG WAY. TWENTY-FIVE TEAMS AND DOZENS OF INDIVIDUALS PARTICIPATED IN THE WALK, AND ENGAGED MORE THAN 260 DONORS TO FUEL RELAPSING POLYCHONDRITIS RESEARCH. "INAUGURAL ERACE FOR RP. RACE FOR RP PARTNERED WITH PODIUM ESPORTS AND MONDAY NIGHT RACING FOR THE INAUGURAL SIMULATION ERACING CHARITY EVENT. THE EVENT WAS HELD ON THE IRACING.COM PLATFORM AT DAYTONA INTERNATIONAL SPEEDWAY'S ROAD COURSE IN A TWO-HOUR TIMED ENDURANCE RACE. THANKS TO THE GENEROSITY OF A LONG-STANDING PARTNER WHO PROVIDED A 3:1 MATCH FOR GIFTS RECEIVED, THE SIM ERACE RAISED 401,000 TO SUPPORT RP AND RELATED AUTOIMMUNE RESEARCH. "NEW RP FOUNDATION WEBSITE. THE RP FOUNDATION DESIGNED AND IMPLEMENTED A NEW, HIGHLY ENGAGING WEBSITE TO INCREASE AWARENESS REGARDING THE BOLD, PURPOSEFUL RESEARCH WE'RE INVESTING IN. |
| FORM 990, PAGE 6, PART VI, LINE 2 | MICHAEL LINN NANCY LINN VICE CHAIR CHAIR SIBLINGS |
| FORM 990, PAGE 6, PART VI, LINE 11B | THE FORM 990 IS PROVIDED TO THE BOARD WHICH IS REVIEWED AND DISCUSSED AT A MEETING. |
| FORM 990, PAGE 6, PART VI, LINE 12C | POLICY IS EMAILED, SIGNED BY MEMBERS AND RETAINED BY TREASURER. THIS IS DONE ANNUALLY. |
| FORM 990, PAGE 6, PART VI, LINE 15A | AN INFORMAL MARKET SURVEY REGARDING PAY RATES AND RESPONSIBILITIES FOR EQUIVALENT DIRECTOR POSITIONS IN SIMILAR NON-PROFIT ORGANIZATIONS WAS PERFORMED. THE RESPONSIBILITIES/ACCOMPLISHMENTS OF THE CURRENT CONTRACTUAL DIRECTOR/PRESIDENT WAS REVIEWED. COMPENSATION WAS BASED ON THE BOARD DISCUSSION AND MARKET SURVEY. |
| FORM 990, PAGE 6, PART VI, LINE 15B | SEE RESPONSE TO 15A. THERE ARE NO OTHER EMPLOYEES. |
| FORM 990, PAGE 6, PART VI, LINE 18 | ALSO AVAILABLE ON WWW.GUIDESTAR.ORG |
| FORM 990, PAGE 6, PART VI, LINE 19 | GOVERNING DOCUMENTS ARE AVAILABLE ON REQUEST. |
| Software ID: | |
| Software Version: |